Antibacterial soluble microneedle
The antibacterial soluble microneedle made of hyaluronic acid, sodium carboxymethylcellulose and copper sulfide doped with phycoerythrin, solve the problems of stability and resistance of existing antibacterial preparations, and achieve efficient bacterial killing and Painless transdermal administration significantly improves treatment efficiency and patient compliance.
Patent Information
- Application Number
- CN202411025284.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
The existing antibacterial preparations have poor stability, poor dispersion and drug resistance when treating bacterial infectious wounds, and the traditional transdermal administration technology is inefficient and the patient's compliance is poor.
Antibacterial soluble microneedles made of hyaluronic acid, sodium carboxymethylcellulose and copper sulfide doped phycoerythrin were prepared by room temperature reaction and freeze-drying method, and ROS was generated in combination with 620nm laser irradiation to kill Bacteria and use sodium carboxymethylcellulose to enhance the solubility and sustained release effect of microneedles.
The stability and dispersion of antibacterial microneedles are significantly improved, good antibacterial effects are achieved, and drug resistance is not generated. The treatment efficiency is significantly improved through efficient transdermal drug delivery technology, and there is no skin irritation and allergic reactions.
Smart Images

Figure BDA0004968366850000051 
Figure BDA0004968366850000061 
Figure BDA0004968366850000062
Abstract
Description
Technical Field
[0001] The present invention relates to a pharmaceutical preparation characterized by a special physical shape, and in particular to a soluble microneedle containing phycoerythrin. The soluble microneedle has an antibacterial effect and is suitable for inhibiting bacterial infection of wounds. Background Art
[0002] Bacterial infection is the most common problem encountered during wound healing and skin regeneration. The severe inflammatory response caused by infection not only significantly increases infection-related complications, but also significantly reduces the quality of wound healing. In addition, the treatment of bacterially infected chronic wounds is difficult, the course of treatment is long, and the cost is high, which imposes a huge economic burden on patients and society. At present, antibiotics are mainly used in clinical treatment of infected wounds. However, due to drug resistance and the lack of a suitable skin repair microenvironment, the treatment effects of anti-infection and wound healing are not ideal. Therefore, it is of great significance to develop novel, efficient, and convenient strategies and preparations for the treatment of bacterial infections.
[0003] The microneedle drug delivery system is a transdermal drug delivery technology that can break through the stratum corneum barrier and is painless. Compared with traditional transdermal drug delivery strategies, it has the advantages of high transdermal efficiency, good patient compliance, and easy self-administration. Copper sulfide (CuS) is a typical antibacterial metal sulfide with significant photothermal and antibacterial properties. Due to its excellent performance and physiological activity, it has been widely used in the field of biomedical engineering, especially as a nanoparticle material with antibacterial components. For example, Li Shuang synthesized chitosan / copper sulfide nanocomposites that are effective in killing bacteria and anti-inflammatory by chemical precipitation (Li Shuang. Synthesis of copper sulfide nanomaterials and their application in antibacterial and cancer cell detection [D]. Northeast Forestry University, 2023.). Xie Yuanxiang used sodium lignin sulfonate as the growth template and dispersion carrier of copper sulfide nanomaterials to prepare lignin-copper sulfide composites, and used the photothermal-catalytic synergistic effect of the composite to enhance the antibacterial properties (Xie Yuanxiang. Preparation and antibacterial properties of lignin-copper sulfide composites [D]. South China University of Technology, 2022.). However, the copper sulfide nanoparticles prepared as above still have the characteristics of poor stability and poor dispersibility, and are still limited in exerting their antibacterial effects.
[0004] Phycoerythrin (R-Phycoerythrin, R-PE) is a light-harvesting protein derived from algae such as red algae and blue-green algae. It is composed of a tetrapyrrole-structured chromophore and apoprotein combined by a thioether bond. Phycoerythrin has good cell affinity and can promote cell proliferation; and phycoerythrin can be used as a photosensitizer to efficiently produce reactive oxygen under laser irradiation, showing good anti-tumor and antibacterial effects. For example, Zang Fan reviewed the structure, preparation, and optical and biological activity applications of phycoerythrin (Zang Fan, Structure, Function and Application of Phycoerythrin, a Light-Harvesting Pigment Protein Unique to Algae [J]. Science Bulletin, 2020, 65, 565). However, there are no reports on the preparation of antibacterial soluble microneedles using phycoerythrin. Summary of the invention
[0005] The technical problem to be solved by the present invention is to provide an antibacterial soluble microneedle, which has a significant antibacterial effect.
[0006] The technical solution of the present invention to solve the above problems is:
[0007] An antibacterial soluble microneedle, which is composed of hyaluronic acid, 25% of sodium carboxymethyl cellulose by weight of the hyaluronic acid, and 15% of copper sulfide by weight of the hyaluronic acid doped with phycoerythrin; wherein the molecular weight of the sodium hyaluronate is 40-50 kDa, and the viscosity of the sodium carboxymethyl cellulose is 1000-1100 mPa.s.
[0008] The copper sulfide doped phycoerythrin is prepared by the following method: adding phycoerythrin to pure water to prepare a phycoerythrin aqueous solution; adding anhydrous copper sulfate in an amount 0.5 times the weight of the phycoerythrin to pure water to prepare a copper sulfate solution; adding sodium sulfide in an amount equimolar to the anhydrous copper sulfate to pure water to prepare a sodium sulfide solution; mixing the copper sulfate solution and the phycoerythrin aqueous solution evenly, adding the sodium sulfide solution, and reacting at room temperature for 8 hours; dialyzing and freeze-drying to obtain the copper sulfide doped phycoerythrin.
[0009] It can be seen from the above-mentioned method for preparing copper sulfide-doped phycoerythrin that there are a large number of copper ions in the copper sulfate solution, which chelate with the side chains on the amino acids of phycoerythrin. When sulfur ions are added, the copper ions and sulfur ions react to form copper sulfide nanoparticles to prepare copper sulfide-doped phycoerythrin.
[0010] The antibacterial soluble microneedles described in the present application are prepared by the following method: adding the copper sulfide-doped phycoerythrin, 50% sodium hyaluronate and sodium carboxymethyl cellulose into water, stirring evenly, and degassing to obtain a needle tip matrix solution; degassing the remaining sodium hyaluronate solvent in water to obtain a backing matrix solution; pouring the needle tip matrix solution into a mold, adding the backing matrix solution, and dehydrating and peeling to obtain the soluble microneedles.
[0011] The soluble microneedles of the present invention show good mechanical properties, biocompatibility and cell affinity. The soluble microneedles of the present invention contain copper sulfide doped phycoerythrin, which can produce ROS and kill bacteria under 620nm laser irradiation, thereby showing good antibacterial properties. The soluble microneedles of the present invention have good antibacterial properties and do not produce drug resistance. The present invention contains sodium carboxymethyl cellulose, which can effectively enhance the dissolution of the soluble microneedles in the skin, accelerate the peeling of the backing layer, and slowly release the copper sulfide doped phycoerythrin. DETAILED DESCRIPTION
[0012] The preparation method and effects of the present invention are further described in detail with specific examples below.
[0013] Example 1
[0014] 1. Preparation of copper sulfide doped phycoerythrin
[0015] Take 100 mg of phycoerythrin and dissolve it in 20 ml of pure water to prepare a phycoerythrin aqueous solution; take 50 mg of anhydrous copper sulfate and dissolve it in 3 ml of pure water to prepare a copper sulfate solution; take 15.6 mg of sodium sulfide and dissolve it in 2 ml of pure water to prepare a sodium sulfide solution; then, under stirring, first slowly add the copper sulfate solution dropwise into the phycoerythrin aqueous solution, then slowly add the sodium sulfide solution dropwise, and stir for 8 hours; dialyze for 24 seconds and then freeze-dry to obtain copper sulfide-doped phycoerythrin.
[0016] The red light spectrum of the copper sulfide-doped phycoerythrin was detected by Thermo Scientific iS20 Fourier transform infrared spectrometer, and the results are as follows: IR: v (cm -1 ), 3242, 1680, 1646. From the infrared data, it can be found that copper sulfide doped phycoerythrin contains amide and ester bonds, indicating that the structure of phycoerythrin itself is not destroyed. The prepared copper sulfide doped phycoerythrin is added into pure water, and it can be seen that the copper sulfide doped phycoerythrin solution has good dispersibility and stability. The particle size can be measured by dynamic light scattering particle size analyzer (DLS) to be 210.11m.
[0017] 2. Preparation of antibacterial soluble microneedles
[0018] Weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa) and 250 mg of sodium carboxymethyl cellulose (viscosity 1000-1100 mPa.s), mix well, add 150 mg of copper sulfide-doped phycoerythrin aqueous solution (1 mg / mL), heat and stir to mix well, and degas to obtain the needle tip matrix material. At the same time, weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa), dissolve in 2 mL of water, and degas to obtain the backing matrix material. Pour the needle tip matrix material into the mold, add the backing matrix material, dehydrate to 1%, and peel off to obtain the antibacterial soluble microneedle.
[0019] 3. Performance testing of antibacterial soluble microneedles
[0020] 3.1. Mechanical properties of soluble microneedles
[0021] The mechanical properties of microneedles determine their ability to penetrate the skin. The prepared soluble microneedles were placed on the lower plate of the texture analyzer, with a compression rate of 1 mm / min and a deformation of 80%. The average pressure change on each needle during the compression process was recorded. When the compression displacement was 400 μm, the pressure on each group of soluble microneedles was greater than 0.73 N / needle, which fully met the requirements for soluble microneedles to penetrate the skin. 3.2. Testing of the transdermal effect and skin recovery ability of soluble microneedles
[0022] Take fresh pigskin, insert the prepared soluble microneedles into the pigskin, press for 1 minute and then remove the backing layer. The results show that the microneedles leave a clear red array on the pigskin, proving that the microneedles have good transdermal ability. Insert the prepared soluble microneedles into the back skin of mice, press for 2 minutes, remove the microneedles, and observe the recovery of the mouse skin in real time. The results show that the back skin of the mice can be completely restored to normal 10 minutes after microneedle puncture, and no abnormal phenomena such as redness and swelling occur, proving that the soluble microneedles described in the present invention have no skin irritation and allergic reaction.
[0023] 3.3 Cell experiments
[0024] Cell seeding
[0025] The prepared soluble microneedle tips were removed and transferred to a 24-well plate. DMEM cell culture medium was added and placed in an incubator for pre-wetting. Mouse epithelial cells L929 were inoculated in the well plate (2.0×10 6 cells / 100 μL / hydrogel), 37°C, 5% CO 2 Culture in the incubator for 4 hours to allow the cells to better adhere to the wall. Then add 1 mL of culture medium to each culture well and incubate at 37°C and 5% CO 2 Culture in an incubator and replace the culture medium every 2 days.
[0026] 3.3.2. Cell viability evaluation
[0027] Take out the 24-well culture plate at 1d, 3d, and 7d, add 80uL MTT solution to each well, and continue to culture in the incubator for 4h. Aspirate the culture medium, add 750uL hydrochloric acid isopropanol solution (0.4mol / L) to each well, incubate in the incubator for 15min, mix well by blowing, take 200uL from each well and transfer it to the 96-well culture plate, and use an automatic microplate reader to detect the light absorption value (OD value) of each well at 540nm.
[0028] Cell viability % = ((test cell OD - blank OD) / (control cell OD - blank OD)) × 100
[0029] The cell viability of the prepared soluble microneedles was tested according to the above method and is shown in Table 1.
[0030] Table 1 Cell viability of soluble microneedles
[0031] Time (day) 1 3 7 Cell viability % 107 133 151
[0032] It can be seen from Table 1 that the prepared soluble microneedles have low cytotoxicity, high cell affinity, and little effect on cell activity.
[0033] Cell adhesion
[0034] The penetration and adhesion of cells were observed macroscopically (MTT staining). Mouse epithelial cells L929 were inoculated in 24 wells containing soluble microneedles, cultured in vitro for 3 days, the culture medium was aspirated, and PBS was rinsed 3 times, 10 minutes each time. 80uL of MTT solution was added to each well and placed in the incubator for further culture for 4h. The culture medium was aspirated and 750μL of hydrochloric acid isopropanol solution (0.4mol / L) was added to each well, incubated in the incubator for 15min, and 200μL of each well was taken and transferred to a 96-well culture plate after mixing by blowing. The light absorption value (OD value) of each well was detected at 540nm using an automatic microplate reader.
[0035] Cell adhesion rate % = ((test cell OD-blank OD) / (control cell OD-blank OD)) × 100
[0036] According to the above method, the cell adhesion rate of the prepared soluble microneedles was 141%. From the cell adhesion rate, it can be seen that the prepared soluble microneedles have high cell affinity.
[0037] 3.3.4 Antibacterial performance testing
[0038] After the soluble microneedles were dissolved (2-fold dilution, phycoerythrin concentration 10-200 μg / mL), Staphylococcus aureus suspension (~10 5The bacteria in the non-laser irradiation group were kept in the dark and incubated at 37°C, and then irradiated with a 620 nm laser (100 mW / cm 2 ) for 10 minutes. All solutions were spread on agarose plates and incubated at 37°C for 12 hours. Each experiment was performed in triplicate. The optical density (OD) of bacteria was read at 600 nm using a microplate reader.
[0039] Staphylococcus aureus suspension (~10 5 CFU / mL) and soluble microneedles were co-cultured and then irradiated with laser (620 nm, 100 mW / cm 2 , 10min). After every 2 hours of incubation, the absorbance of the solution at 600nm was recorded to calculate the bacterial growth curve.
[0040] The bacterial survival rate of soluble microneedles treated with the microneedles was 66.4%, which indicates that the soluble microneedles have a certain antibacterial effect. However, the bacterial survival rate of soluble microneedles and light treatment was 1.03%, indicating that the soluble microneedles after light exposure showed a good antibacterial effect. This is attributed to the fact that under light, the soluble microneedles produce ROS, thereby inhibiting bacteria. And under laser irradiation, the minimum inhibitory concentration (MIC) of the soluble microneedles is 63.2μg / mL (copper sulfide doped phycoerythrin concentration). The bacterial growth curve shows that soluble microneedles plus laser irradiation can inhibit bacterial growth. Therefore, from the above results, it can be concluded that the soluble microneedles have good antibacterial properties.
[0041] 3.3.5 Drug resistance test
[0042] The soluble microneedle tip was removed and dissolved in PBS to prepare different concentrations of test solution. The test solution of different concentrations was co-cultured with Staphylococcus aureus and then irradiated with laser (620nm, 100mW / cm 2 , 10min), and examine its minimum inhibitory concentration (MIC). Let Staphylococcus aureus grow for 5 generations, and examine the change of its MIC. The results show that the MIC of the soluble microneedles prepared in Example 1 has no obvious change, proving that the soluble microneedles described in the present invention will not cause Staphylococcus aureus to develop drug resistance under laser irradiation.
[0043] Example 2 (comparative experiment)
[0044] 1. Preparation of Phycoerythrin-Hyaluronic Acid Soluble Microneedles
[0045] Unmodified phycoerythrin was dissolved in water to prepare an aqueous solution with a concentration of 1 mg / mL.
[0046] Weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa) and 250 mg of sodium carboxymethyl cellulose (viscosity 1000-1100 mPa.s), mix well, add 150 mg of phycoerythrin aqueous solution (1 mg / mL), heat and stir to mix well, and degas to obtain the needle tip matrix material. At the same time, weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa), dissolve in 2 mL of water, and degas to obtain the backing matrix material. Pour the needle tip matrix material into the mold, add the backing matrix material, dehydrate to 1%, and peel off to obtain the phycoerythrin-hyaluronic acid soluble microneedle.
[0047] 2. Preparation of copper sulfide-hyaluronic acid soluble microneedles
[0048] Copper sulfide nanoparticles were prepared according to the method described in Patent 202211518750.9, and an aqueous solution with a concentration of 1 mg / mL was prepared.
[0049] Weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa) and 250 mg of sodium carboxymethyl cellulose (viscosity 1000-1100 mPa.s), mix well, add 150 mg of copper sulfide nanoparticle aqueous solution (1 mg / mL), heat and stir to mix well, and degas to obtain the needle tip matrix material. At the same time, weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa), dissolve it in 2 mL of water, and degas to obtain the backing matrix material. Pour the needle tip matrix material into the mold, add the backing matrix material, dehydrate to 1%, and peel off to obtain the copper sulfide-hyaluronic acid soluble microneedle.
[0050] 3. Preparation of Hyaluronic Acid Soluble Microneedles
[0051] Weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa) and 250 mg of sodium carboxymethyl cellulose (viscosity 1000-1100 mPa.s), heat and stir to mix, and degas to obtain the needle tip matrix material. At the same time, weigh 500 mg of sodium hyaluronate (molecular weight 40-50 kDa), dissolve it in 2 mL of water, and degas to obtain the backing matrix material. Pour the needle tip matrix material into the mold, add the backing matrix material, dehydrate to 1%, and peel off to obtain the hyaluronic acid soluble microneedle.
[0052] 4. Comparison of antibacterial properties
[0053] The antibacterial properties of the soluble microneedles prepared in Example 1 and the above three soluble microneedles were tested and compared according to the method described in Example 1. The results are shown in Table 2.
[0054] Table 2 Antibacterial properties of different soluble microneedles
[0055]
[0056]
[0057] It can be seen from Table 2 that the soluble microneedles prepared in Example 1 show a more excellent antibacterial effect.
[0058] 4. Comparison of cell affinity of soluble microneedles
[0059] The cell affinity of the soluble microneedles prepared in Example 1 and the above three soluble microneedles was tested according to the method described in Example 1. The results are shown in Table 3.
[0060] Table 3 Cell affinity properties of different soluble microneedles
[0061]
[0062] It can be seen from Table 3 that the antibacterial soluble microneedles prepared in Example 1 show more excellent cell affinity.
Claims
1. An antibacterial soluble microneedle, the microneedle is made of hyaluronic acid, 25% of sodium carboxymethyl cellulose by weight of the hyaluronic acid, and 15% of copper sulfide by weight of the hyaluronic acid doped with phycoerythrin; wherein, The molecular weight of the sodium hyaluronate is 40 to 50 kDa. The viscosity of the sodium carboxymethyl cellulose is 1000-1100 mPa.s; The copper sulfide-doped phycoerythrin is prepared by the following method: adding phycoerythrin to pure water to obtain a phycoerythrin aqueous solution; adding anhydrous copper sulfate in an amount 0.5 times the weight of the phycoerythrin to pure water to obtain a copper sulfate solution; taking sodium sulfide in an amount equimolar to the anhydrous copper sulfate and adding it to pure water to obtain a sodium sulfide solution; mixing the copper sulfate solution and the phycoerythrin aqueous solution evenly, adding the sodium sulfide solution, reacting at room temperature for 8 hours, and dialyzing and freeze-drying to obtain the copper sulfide-doped phycoerythrin.
2. The antibacterial soluble microneedle according to claim 1, characterized in that: The antibacterial soluble microneedle is prepared by the following method: adding the copper sulfide doped phycoerythrin, 50% sodium hyaluronate and sodium carboxymethyl cellulose into water, stirring evenly, and obtaining a needle tip matrix solution after degassing; degassing the remaining sodium hyaluronate solvent in water to obtain a backing matrix solution; then pouring the needle tip matrix solution into a mold, adding the backing matrix solution, and dehydrating and peeling to obtain the soluble microneedle.
